Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-03-12
1992-03-03
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514913, A61K 3134
Patent
active
050933299
ABSTRACT:
Disclosed are a method and composition for treating ocular hypertension. The compositions comprise prostaglandin-like 7-oxabicyclo derivatives which have been discovered to exhibit a pronounced intraocular pressure reducing effect, but with substantially reduced adverse side effects characteristic of the corresponding prostaglandin.
REFERENCES:
patent: 4537981 (1985-08-01), Snitman et al.
patent: 4654366 (1987-03-01), Varma et al.
patent: 4673685 (1987-01-01), Varma et al.
Chem. Abst. 102:1050c (1985), Harris et al.
Allergan Inc.
Baran Robert J.
Fay Zohreh
Voet Martin A.
Waddell Frederick E.
LandOfFree
Intraocular pressure reducing prostaglandin-like 7-oxabicyclo de does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraocular pressure reducing prostaglandin-like 7-oxabicyclo de, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraocular pressure reducing prostaglandin-like 7-oxabicyclo de will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-272289